wildpixel/iStock via Getty Images
Acadia Pharmaceuticals (NASDAQ:ACAD) soared 20% after a court ruling in patent suit regarding its drug Nuplazid, which is used to treat Parkinson’s disease.
The court ruled that Aurobindo Pharma infringes claims 4 and 5 of its ‘721 patent, U.S. District Court Judge Gregory